Skip to content
UPDATE: Section 122 tariff (10%) in effect since Feb 24 — expires ~July 24 (~126 days). 24 states challenge in court (March 5). USTR launches new Section 301 probes (March 11). EU trade deal vote imminent. Full analysis →
Tariffs Tool
🇮🇳

US Tariffs on Imports from India

Updated 2026-03-20
Updated Feb 21, 2026: IEEPA tariff (was 18%) struck down by SCOTUS Feb 20. Replaced by 10% Section 122 tariff (effective Feb 24, expires ~July 24). Rate decreased from 18% to 10%. Section 122 tariffs expire ~July 24, 2026.
Section 122 Tariff
10%
was 18% (IEEPA)
232 Steel
50%
232 Aluminum
50%
Rate dropped from 18% (IEEPA) to 10% (Section 122). US-India Interim Agreement IEEPA provisions now moot.

India Import Tariff Overview

India saw its tariff rate drop from 26% (IEEPA, later reduced to 18% by the US-India Interim Agreement) to 10% under Section 122. Combined with the Interim Agreement's 0% provisions on designated products, India is now the most competitive major Asian sourcing alternative to China at $87B in annual US imports.

The US-India trade relationship has evolved rapidly: the Feb 2 Interim Agreement reduced the IEEPA rate from 26% to 18%, then the Feb 20 SCOTUS ruling replaced that with 10% Section 122. India was removed from GSP in 2019 but these recent developments partially offset that loss. India is positioning itself as the premier China+1 alternative, with Apple, Samsung, and other companies expanding Indian electronics manufacturing.

Key Products Imported from India

Top imports include pharmaceuticals and generic drugs, gems and jewelry (particularly cut diamonds), textiles and apparel, organic chemicals, IT services-related hardware, seafood (shrimp), and machinery. India is the world's largest supplier of generic medications and a growing electronics assembly hub.

Recent Changes

Feb 20, 2026: SCOTUS struck down IEEPA tariffs — India's rate dropped to 10% Section 122 (from 18% under the Interim Agreement, originally 26% IEEPA). The US-India Interim Agreement provisions for 0% on designated products may still apply under the Section 122 framework. Section 232 tariffs of 50% remain. Apple's iPhone production in India continues expanding. A comprehensive FTA is still being negotiated.

Tips for Importers

India's 10% Section 122 rate makes it exceptionally competitive for textiles and apparel — compare with Chinese goods that face an additional 25% Section 301 on top of the same 10%. Indian pharmaceuticals enter at 0% MFN, making the 10% Section 122 tariff the only layer. Check whether your products still qualify for 0% under the US-India Interim Agreement's designated product lists. Gems and jewelry classification varies significantly by processing stage — cut diamonds face different rates than rough stones.

Rates by Product Sector

SectorBase RateSurchargeEffective RateNotes
Electronics0%Free
Clothing & Apparel16.5%16.5%
Textiles & Fabrics9%9%
Pharmaceuticals0%Free100% on patented pharma
Chemicals3%3%

Calculate Duty from India

Tariff rates change fast. Stay ahead.

Free alerts when US import tariff rates change. Join importers and trade professionals who stay informed.

No spam. Unsubscribe anytime.

Frequently Asked Questions

Does the US-India Interim Agreement still matter after the SCOTUS ruling?
The Interim Agreement's provisions for 0% duties on designated products may still provide benefits beyond the Section 122 rate. However, the across-the-board Section 122 rate of 10% is already lower than the 18% the Interim Agreement had negotiated, so for most products the SCOTUS ruling provides greater relief.
How competitive is India versus Vietnam for apparel sourcing?
Both now face 10% Section 122, creating a level playing field on tariffs for the first time since IEEPA tariffs were imposed. The competition now shifts to labor costs, production capacity, lead times, and quality — areas where both countries have different strengths.
Are Indian generic pharmaceuticals affected by tariffs?
Most finished pharmaceutical products enter at 0% MFN duty, making the 10% Section 122 tariff the only cost layer. India supplies over 40% of US generic drug prescriptions, and the relatively low tariff burden helps maintain affordable medication access.
Is India benefiting from the Apple supply chain shift?
Yes. Apple has expanded iPhone production in India (through Foxconn and Tata Electronics), and the reduction from 26% IEEPA to 10% Section 122 makes Indian-assembled electronics significantly more competitive for US import. India is positioning to become a major smartphone export hub.

Related Countries

Related Product Categories

Popular Tariff Lookups